Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose

Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood Glucose Compared to Current Screening in the Priority Health Area of Saint-Etienne and the Sainté Diabète Network.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02440555

Acronym

Sainté Diabète

Enrollment

1305

Registered

2015-05-12

Start date

2014-11-30

Completion date

2015-03-31

Last updated

2016-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

diabetes, capillary blood glucose, self-administered questionnaire

Brief summary

Type 2 diabetes is the chronic disease with the most important development in France, and particularly in the Saint-Etienne area due to his specific population. Different studies showed the interest of screening targeted on high risk population to reduce cardiovascular risks and mortality. The current screening recommandation is an opportunist targeted screening on population older than 45 years with risk factors by a fasting glucose every 3 years, and a communautaire screening targeted on population older than 45 years suffering precarity with or without risk factors by capillary blood glucose or fasting glucose. The objective of the Sainté Diabete network is to optimize the screening of diabetics, their follow-up and their treatments. Using a self-administered questionnaire during a medical visit could be a simple, cheap and efficient tool to detect diabetics as soon as possible.

Interventions

OTHERfulfill the self-administered questionnaire

Patients viewed in a pharmacy or a hospital fulfill the self-administered questionnaire before having a capillary blood glucose measurement.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

45 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Man or woman * 45 years or older * Signed informed consent

Exclusion criteria

* fasting glucose performed in the last 2 years * diabetes history * not living in Saint-Etienne

Design outcomes

Primary

Measure	Time frame	Description
Sensitivity of detection of type 2 diabetes	Day 1 (inclusion day)	To evaluate the sensitivity (true positive) of detection of type 2 diabetes by a self-administered questionnaire performed in a pharmacy or a hospital compared to capillary blood glucose measurements in the same population from the priority health area of Saint-Etienne.

Secondary

Measure	Time frame	Description
Specificity of detection of type 2 diabetes	Day 1 (inclusion day)	To evaluate the specificity (true negative) of detection of type 2 diabetes by a self-administered questionnaire performed in a pharmacy or a hospital compared to capillary blood glucose measurements in the same population from the priority health area of Saint-Etienne
To evaluate the cost of the targeted screening and the screening accessibility to population from the priority health area of Saint-Etienne	Month 2	—
To evaluate the numbers of patients screened by self-administered questionnaire and diagnosed as diabetics using fasting glucose.	Month 2	—

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026